Ying Lin

1.0k total citations · 1 hit paper
41 papers, 668 citations indexed

About

Ying Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ying Lin has authored 41 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Ying Lin's work include Lung Cancer Treatments and Mutations (3 papers), Extracellular vesicles in disease (3 papers) and Metastasis and carcinoma case studies (3 papers). Ying Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Extracellular vesicles in disease (3 papers) and Metastasis and carcinoma case studies (3 papers). Ying Lin collaborates with scholars based in China, Japan and Sweden. Ying Lin's co-authors include Xiaohong Chen, Zheng Wu, John J. Schwab, Barbara L. Kennedy, Wei Zhu, Xiaoxiao Ge, Congqi Dai, Fengjuan Lin, Yasuo Tsutsumi and Kazuma Higashisaka and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Scientific Reports.

In The Last Decade

Ying Lin

40 papers receiving 661 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

YouTube/ Bilibili/ TikTok videos as sources of medical information on laryngeal carcinoma: cross-sectional content analysis study

2024 40 citations Yiwen Chen, Ying Lin et al. BMC Public Health profile →

Peers

Ying Lin

ONCOL

IMMUN

PRM

Kelsey K. Baker United States

Sanghee Park South Korea

Claire Henry New Zealand

Matthias Unseld Austria

Yaxiong Sang China

Regina Demlová Czechia

Alissa Huston United States

Ismael Ghanem Spain

Ibtissam Youlyouz‐Marfak Morocco

Yize Mao China

Kelsey K. Baker United States

Ying Lin

268 ×1.2

ONCOL

104 ×0.5

113 ×0.9

IMMUN

131 ×1.1

PRM

66 ×0.6

Citations per year, relative to Ying Lin Ying Lin (= 1×) peers Kelsey K. Baker

Countries citing papers authored by Ying Lin

Since Specialization

Citations

This map shows the geographic impact of Ying Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Lin more than expected).

Fields of papers citing papers by Ying Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Lin. The network helps show where Ying Lin may publish in the future.

Co-authorship network of co-authors of Ying Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Lin. A scholar is included among the top collaborators of Ying Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Lin. Ying Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Jun, Miao Zhao, Ying Lin, et al.. (2025). TAF1 acetyltransferase promotes colorectal carcinoma metastasis by catalyzing β-hydroxybutyrylation of KCTD9. Oncogene. 45(1). 87–103.

Chen, Yiwen, et al.. (2024). YouTube/ Bilibili/ TikTok videos as sources of medical information on laryngeal carcinoma: cross-sectional content analysis study. BMC Public Health. 24(1). 1594–1594. 40 indexed citations breakdown →

Lin, Ying, Bo Yu, Hongyu Zhang, et al.. (2023). Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. Journal of Cancer Research and Clinical Oncology. 149(11). 8663–8671. 20 indexed citations

Zhang, Yao, Ying Lin, Chang Liu, et al.. (2023). Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single‐center retrospective study. Journal of Digestive Diseases. 24(8-9). 472–479. 3 indexed citations

Lai, Hongyan, Chang Liu, Xin Zhang, et al.. (2023). Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer. Cancer Science. 114(7). 2774–2786. 6 indexed citations

Liu, Qiang, et al.. (2023). Beneficial Effect of Toxoplasma gondii Infection on the Prognosis of Breast Cancer Was Modified by Cytokines. Clinical Epidemiology. Volume 15. 469–481. 6 indexed citations

Hu, Linhui, Hualiang Lv, Zhihua Chen, et al.. (2022). Effects of Juhongtanke oral solution on alleviating the symptoms of community-acquired pneumonia: A multicenter, prospective, randomized controlled trial. Frontiers in Pharmacology. 13. 1027901–1027901. 1 indexed citations

Lin, Ying, et al.. (2022). Osimertinib-tolerant lung cancer cells are susceptible to ferroptosis. Biochemical and Biophysical Research Communications. 641. 116–122. 8 indexed citations

Liu, Chang, Xianghua Wu, Hui Yu, et al.. (2021). Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations. Frontiers in Oncology. 11. 752545–752545. 4 indexed citations

10.

Zhu, Zhu, et al.. (2021). Cross-sectional study on the SF-36, the general self-efficacy, the social support, and the health promoting lifestyle of the young elderly in a community in Shanghai, China. Annals of Palliative Medicine. 10(1). 518–529. 18 indexed citations

11.

Lin, Ying, Mingxi Lin, Jian Zhang, et al.. (2020). Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis. Cancer Research and Treatment. 52(4). 1059–1066. 34 indexed citations

12.

Lin, Ying, Kazuma Higashisaka, Takuya Shintani, et al.. (2020). Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells. Scientific Reports. 10(1). 4748–4748. 21 indexed citations

13.

Sun, Guoqiang, Qi Wang, Ying Lin, et al.. (2020). Perinatal Depression of Exposed Maternal Women in the COVID-19 Pandemic in Wuhan, China. Frontiers in Psychiatry. 11. 26 indexed citations

14.

Lin, Ying, Wei Zhu, & Xiaohong Chen. (2020). The involving progress of MSCs based therapy in atherosclerosis. Stem Cell Research & Therapy. 11(1). 216–216. 33 indexed citations

15.

Shao, Nan, Yawei Shi, Liang Yu, et al.. (2019). Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer. International Journal of Biological Sciences. 15(5). 962–972. 14 indexed citations

16.

Lin, Ying, Zhongxing Wang, Songqi Li, et al.. (2019). Surgery in initially metastatic breast cancer: prognosis is associated with patient characteristics and timing of surgery.. PubMed. 24(2). 543–548. 2 indexed citations

17.

Higashisaka, Kazuma, Akitoshi Nakashima, Aiko Aoki, et al.. (2018). Neutrophil Depletion Exacerbates Pregnancy Complications, Including Placental Damage, Induced by Silica Nanoparticles in Mice. Frontiers in Immunology. 9. 1850–1850. 16 indexed citations

18.

Jing, Xiaogang, et al.. (2017). Video-assisted thoracoscopic lobectomy mitigates adverse oncological effects of delayed adjuvant chemotherapy for nonsmall cell lung cancer patients.. PubMed. 21(6). 1524–1529. 4 indexed citations

19.

Zhang, Jian, Ying Lin, Xichun Hu, Zheng Wu, & Weijian Guo. (2017). VPS52 induces apoptosis via cathepsin D in gastric cancer. Journal of Molecular Medicine. 95(10). 1107–1116. 12 indexed citations

20.

Lin, Fengjuan, Congqi Dai, Xiaoxiao Ge, et al.. (2017). Prognostic significance and functional implication of immune activating receptor NKG2D in gastric cancer. Biochemical and Biophysical Research Communications. 487(3). 619–624. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact